Khalid, et al. “ROLE OF SGLT-2 INHIBITORS (GLIFLOZINS) AND CARDIORENAL OUTCOME IN PATIENTS WITH OR WITHOUT DIABETES”. Journal of Population Therapeutics and Clinical Pharmacology, vol. 30, no. 18, Oct. 2023, pp. 1001-9, https://doi.org/10.53555/jptcp.v30i18.3220.